Published in PLoS One on January 23, 2012
YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. EMBO J (2013) 0.94
YY1 is indispensable for Lgr5+ intestinal stem cell renewal. Proc Natl Acad Sci U S A (2014) 0.88
Genetic variation at a Yin-Yang 1 response site regulates the transcription of cyclin-dependent kinase inhibitor p18INK4C transcript in lupus-prone mice. J Immunol (2012) 0.84
Yin Yang 1 Promotes Thymocyte Survival by Downregulating p53. J Immunol (2016) 0.76
Nitric oxide has contrasting age-dependent effects on the functionality of murine hematopoietic stem cells. Stem Cell Res Ther (2016) 0.75
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell (2005) 24.00
The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Stem cells and cancer; the polycomb connection. Cell (2004) 7.43
Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell (1981) 6.31
The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. Mol Cell (1998) 5.79
Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science (2000) 4.53
Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet (1995) 4.39
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene (2006) 4.06
Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A (1991) 3.71
Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev (2004) 3.66
Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell (2002) 3.56
Transcription factor GATA-3 is required for development of the T-cell lineage. Nature (1996) 3.51
Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene (1999) 3.29
Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity (2004) 3.25
Yin Yang 1 is a negative regulator of p53. Cell (2004) 3.24
Transcriptional control of early B cell development. Annu Rev Immunol (2004) 3.22
Yin Yang 1 is a critical regulator of B-cell development. Genes Dev (2007) 3.06
The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood (2005) 2.99
Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol (2003) 2.96
Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev (1995) 2.93
Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol (1999) 2.61
Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J (2002) 2.49
Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol Cell Biol (2006) 2.48
A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol (1987) 2.48
Contingent gene regulatory networks and B cell fate specification. Proc Natl Acad Sci U S A (2005) 2.36
Transcriptional networks in developing and mature B cells. Nat Rev Immunol (2005) 2.07
Yin-yang 1 activates the c-myc promoter. Mol Cell Biol (1993) 2.06
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood (2005) 1.96
Transcription factor YY1 functions as a PcG protein in vivo. EMBO J (2003) 1.95
Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol (2005) 1.89
Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci U S A (2006) 1.82
A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene (2002) 1.70
A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol (2007) 1.68
Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol (1999) 1.52
YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev (2004) 1.52
Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood (1982) 1.52
A unique function for cyclin D3 in early B cell development. Nat Immunol (2006) 1.51
Multiple mechanisms of transcriptional repression by YY1. Mol Cell Biol (1997) 1.50
Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood (2002) 1.48
Cyclin D3 is selectively required for proliferative expansion of germinal center B cells. Mol Cell Biol (2010) 1.24
Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3. Dev Biol (2002) 1.17
Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis. Exp Hematol (2001) 1.17
Requirement for cyclin D3 in germinal center formation and function. Cell Res (2010) 1.16
Interaction between YY1 and the retinoblastoma protein. Regulation of cell cycle progression in differentiated cells. J Biol Chem (2000) 1.16
Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp Hematol (2004) 1.14
The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood (2002) 1.12
Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. J Biol Chem (1998) 1.09
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res (1996) 1.06
Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue. J Cell Biochem (2005) 1.04
YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene (1998) 1.00
YY1 helps to bring loose ends together. Genes Dev (2007) 0.99
YY1 restrained cell senescence through repressing the transcription of p16. Biochim Biophys Acta (2008) 0.97
PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol Cell Biol (2009) 0.94
Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3. J Immunol (2003) 0.89
Transcription factors controlling the beginning and end of B-cell differentiation. Curr Opin Genet Dev (2003) 0.86
Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression. Nucleic Acids Res (1996) 0.85
Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death. Eur J Cell Biol (2005) 0.85
B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages. Exp Cell Res (2006) 0.83
HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1. Biochim Biophys Acta (2003) 0.82
Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet (2007) 10.78
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest (2007) 9.33
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet (2006) 7.53
Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol (2006) 4.96
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol (2002) 4.50
Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol (2005) 3.26
A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci U S A (2008) 3.10
Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci U S A (2007) 3.10
Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell (2009) 3.05
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A (2013) 2.95
Notch signaling is an important regulator of type 2 immunity. J Exp Med (2005) 2.87
Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res (2009) 2.64
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature (2008) 2.51
Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development (2011) 2.45
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab (2002) 2.24
Notch signaling in cancer. Cancer Biol Ther (2002) 2.20
Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol (2006) 2.01
CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell (2011) 2.01
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood (2011) 1.99
Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res (2005) 1.99
Transcription factor YY1 functions as a PcG protein in vivo. EMBO J (2003) 1.95
Selective thymus settling regulated by cytokine and chemokine receptors. J Immunol (2007) 1.92
Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci U S A (2005) 1.91
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol Cell Biol (2004) 1.90
Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc Natl Acad Sci U S A (2006) 1.82
Wnt proteins promote bone regeneration. Sci Transl Med (2010) 1.80
Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell (2006) 1.76
The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans. Blood (2007) 1.73
Predicting solar cycle 24 with a solar dynamo model. Phys Rev Lett (2007) 1.71
Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification. Blood (2008) 1.67
Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology (2012) 1.66
T-ing up inflammation in fat. Nat Med (2009) 1.66
Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res (2004) 1.65
Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem (2007) 1.65
Time-resolved mechanism of extracellular gate opening and substrate binding in a glutamate transporter. J Biol Chem (2008) 1.61
From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev (2010) 1.60
Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell (2008) 1.58
GATA-3 is required for early T lineage progenitor development. J Exp Med (2009) 1.56
An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth. Cancer Biol Ther (2003) 1.52
YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev (2004) 1.52
Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals. J Bone Joint Surg Am (2013) 1.52
Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood (2002) 1.48
A polycomb group protein, PHF1, is involved in the response to DNA double-strand breaks in human cell. Nucleic Acids Res (2008) 1.47
Clopidogrel: is a surgical delay necessary in fractured neck of femur? Ann R Coll Surg Engl (2011) 1.47
Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab (2009) 1.45
Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril (2012) 1.43
Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res (2013) 1.43
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. J Clin Invest (2014) 1.38
The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood (2009) 1.36
B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5. Nat Immunol (2004) 1.34
Physiology of phototrophic iron(II)-oxidizing bacteria: implications for modern and ancient environments. FEMS Microbiol Ecol (2008) 1.31
Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J Clin Invest (2013) 1.27
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease. Blood (2010) 1.21
Multiple prethymic defects underlie age-related loss of T progenitor competence. Blood (2007) 1.19
Recruitment of mismatch repair proteins to the site of DNA damage in human cells. J Cell Sci (2008) 1.19
Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol Ther (2009) 1.18
The MeTeOR trial (Meniscal Tear in Osteoarthritis Research): rationale and design features. Contemp Clin Trials (2012) 1.17
Functional characterization of CD4+ T cells in aplastic anemia. Blood (2011) 1.17
B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer (2009) 1.16
Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells. Cancer Res (2005) 1.16
Anterior cruciate ligament revision reconstruction: two-year results from the MOON cohort. J Knee Surg (2007) 1.15
Interface tissue engineering and the formulation of multiple-tissue systems. Adv Biochem Eng Biotechnol (2006) 1.15
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther (2008) 1.15
Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet (2012) 1.15
MicroRNAs in erythropoiesis. Curr Opin Hematol (2010) 1.15
Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology (2006) 1.14
GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry. Blood (2012) 1.14
The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res (2009) 1.14
Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. Blood (2006) 1.13
T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage. Blood (2006) 1.11
Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. Proc Natl Acad Sci U S A (2007) 1.10
CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest (2012) 1.09
HER2 targeted molecular MR imaging using a de novo designed protein contrast agent. PLoS One (2011) 1.09
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet (2013) 1.09
Cross-cultural comparison of patients undergoing ACL reconstruction in the United States and Norway. Knee Surg Sports Traumatol Arthrosc (2010) 1.09
Charge transport in carbon nanotubes: quantum effects of electron-phonon coupling. J Phys Condens Matter (2007) 1.07
Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. Br J Haematol (2006) 1.06
Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet (2010) 1.06
B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Invest (2007) 1.05
Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer. Tohoku J Exp Med (2014) 1.05
Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue. J Cell Biochem (2005) 1.04
Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema. Neurochem Int (2011) 1.02
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am (2004) 1.02
Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. Cancer Res (2012) 1.01
Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1. J Biol Chem (2003) 1.01
Graft-versus-leukemia in a retrovirally induced murine CML model: mechanisms of T-cell killing. Blood (2004) 1.01
Revision ACL reconstruction outcomes: MOON cohort. J Knee Surg (2011) 1.01
Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells. J Clin Invest (2015) 1.00
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53. Cancer Res (2009) 0.99
The Notch 'gospel'. EMBO Rep (2005) 0.99
Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. Eur J Immunol (2010) 0.99
Notch signaling in the hematopoietic system. Expert Opin Biol Ther (2009) 0.97
Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle (2012) 0.97
Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. J Immunol (2005) 0.96